Literature DB >> 19147269

Androgens and morphologic remodeling at penile and cardiovascular levels: a common piece in complicated puzzles?

Vincenzo Mirone1, Ciro Imbimbo, Ferdinando Fusco, Paolo Verze, Massimiliano Creta, Gianfranco Tajana.   

Abstract

CONTEXT: Epidemiologic data demonstrate a protective role by normal androgen levels on cardiovascular health and erectile function. Low androgen levels are associated with erectile dysfunction and increased risk of cardiovascular diseases. Both conditions recognize as anatomic substrate a pathologic structural remodeling. Direct androgen effects on male external genitalia, vascular wall, and myocardium have been reported.
OBJECTIVE: To review current knowledge about androgen-dependent molecular signaling pathways and cellular events within penile and cardiovascular tissues involved in the homeostatic control of morphologic tissue properties and in the development of structural remodeling in presence of normal and low androgen levels, respectively. EVIDENCE ACQUISITION: A literature search was performed in November 2008 using the commercially available Medline online engine search to retrieve studies (from 1998 to 2008) on the mechanisms mediating the role of androgens on penile and cardiovascular morphologic homeostasis and remodeling. A combination of the following medical subject headings was used: androgens, hypogonadism, vessel tissue architecture, remodeling, cardiovascular system, and penis. EVIDENCE SYNTHESIS: Androgens exert direct beneficial effects on both cardiovascular and penile tissues. Endothelial cells and smooth-muscle cells are the main cellular targets for direct androgen effects in both tissues and are involved in pathologic remodeling in hypogonadal models. At vascular level, androgens promote endothelial cell survival, reduce endothelial expression of proinflammatory markers, and inhibit proliferation and intimal migration of vascular smooth-muscle cells. At penile level, low androgen levels are associated with apoptosis of endothelial cells and smooth-muscle cells. Moreover, low androgen levels impair proliferation, migration, and homing of endothelial progenitor cells as well as myogenic differentiation of mesenchymal progenitor cells.
CONCLUSIONS: Normal androgen levels promote vascular and penile homeostasis by direct mechanisms mainly involving endothelial cells and smooth-muscle cells. Low androgen levels are associated with impairments of such mechanisms, leading to pathologic structural remodeling.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19147269     DOI: 10.1016/j.eururo.2008.12.037

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  12 in total

1.  Erectile tissue molecular alterations with aging: differential activation of the p42/44 MAP Kinase pathway.

Authors:  Angela Castela; Raquel Soares; Fátima Rocha; Pedro Vendeira; Ronald Virag; Carla Costa
Journal:  Age (Dordr)       Date:  2010-07-14

Review 2.  Translational Perspective on the Role of Testosterone in Sexual Function and Dysfunction.

Authors:  Carol A Podlasek; John Mulhall; Kelvin Davies; Christopher J Wingard; Johanna L Hannan; Trinity J Bivalacqua; Biljana Musicki; Mohit Khera; Nestor F González-Cadavid; Arthur L Burnett
Journal:  J Sex Med       Date:  2016-08       Impact factor: 3.802

3.  Androgen depletion in humans leads to cavernous tissue reorganization and upregulation of Sirt1-eNOS axis.

Authors:  Inês Tomada; Nuno Tomada; Henrique Almeida; Delminda Neves
Journal:  Age (Dordr)       Date:  2011-11-04

4.  Different profile of endothelial cell apoptosis in patients with Klinefelter's syndrome.

Authors:  R A Condorelli; A E Calogero; S La Vignera
Journal:  J Endocrinol Invest       Date:  2012-03-06       Impact factor: 4.256

Review 5.  Lack of exercise is a major cause of chronic diseases.

Authors:  Frank W Booth; Christian K Roberts; Matthew J Laye
Journal:  Compr Physiol       Date:  2012-04       Impact factor: 9.090

6.  Testosterone, endothelial health, and erectile function.

Authors:  Angela Castela; Pedro Vendeira; Carla Costa
Journal:  ISRN Endocrinol       Date:  2011-09-06

Review 7.  Erectile dysfunction, metabolic syndrome, and cardiovascular risks: facts and controversies.

Authors:  Edward Sanchez; Alexander W Pastuszak; Mohit Khera
Journal:  Transl Androl Urol       Date:  2017-02

8.  Deterioration of Chronotropic Responses and Heart Rate Recovery Indices in Men With Erectile Dysfunction.

Authors:  Faruk Kucukdurmaz; Gurkan Acar; Sefa Resim
Journal:  Sex Med       Date:  2017-12-21       Impact factor: 2.491

Review 9.  Understanding Erectile Dysfunction in Hypertensive Patients: The Need for Good Patient Management.

Authors:  Jorge Hernández-Cerda; Vicente Bertomeu-González; Pilar Zuazola; Alberto Cordero
Journal:  Vasc Health Risk Manag       Date:  2020-06-12

10.  The correlation between erectile dysfunction and metabolic syndrome in an Indian population: A cross-sectional observational study.

Authors:  Rajeev Sood; Dushiant Sharma; Hemant Goel; Nikhil Khattar; Bindu Kulshreshtha; Kunal K Singh
Journal:  Arab J Urol       Date:  2019-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.